Skip to main content
. Author manuscript; available in PMC: 2020 Jan 2.
Published in final edited form as: J Thorac Cardiovasc Surg. 2018 Apr 4;156(2):894–905.e3. doi: 10.1016/j.jtcvs.2018.03.112

TABLE 2.

Demographic composition of all patients evaluated divided in to 2 groups

Characteristic Group 1 Group 2 P value
Age, mean ± SD 48 ± 13 y 50 ± 14 y
Sex 51% male, 49% female 59% male, 41% female
Emphysema 52% 25.8%
Cystic fibrosis 18.2% 17.7%
Pulmonary fibrosis 16.1% 46%
Pulmonary vascular disease 7.2% 1.6%
Double or single transplant 77.7% double, 22.3% single 96.2% double, 3.8% single
Primary graft dysfunction 22.1% 31.6% <.001
Hospital mortality 4.4% 3.5% <.4
1-y survival 84.3% 89.3% <.02

Group 1 (before introduction of lung allocation score); Group 2 (after introduction of lung allocation score). Primary graft dysfunction (PGD) is defined as PGD grade 3 identified from the time of transplant to 72 hours post-transplant. SD, Standard deviation.